A carregar...
Biological therapies for atrial fibrillation: ready for prime time?
Atrial fibrillation is a prominent cause of morbidity and mortality in developed countries. Treatment strategies center on controlling atrial rhythm or ventricular rate. The need for anticoagulation is an independent decision from the rate vs. rhythm control debate. This review discusses novel biolo...
Na minha lista:
| Publicado no: | J Cardiovasc Pharmacol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879872/ https://ncbi.nlm.nih.gov/pubmed/26222989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000293 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|